Increasing cases of trauma and rising number of hospital and trauma care centers facilitating emergency treatments are key factors driving market revenue growth.
Market Size - USD 1,850.5 Million in 2020, Market Growth - CAGR of 4.7%, Market Trends - Rising investment by companies in research and development of innovative and technologically advanced immunohematology devices.
The global immunohematology market size is expected to reach USD 2,678.9 Million in 2028, and register a CAGR of 4.7% during the forecast period. Increasing prevalence of hematological disease, rising demand for platelet and plasma, especially during COVID pandemic, and immune-globin, rapidly increasing number of blood banks by government and private institutions, and increasing incidence of blood-transfusion related diseases are some of the major factors driving market growth. In addition, major players are focusing and investing in improving safety and longevity of blood stored in the blood banks by innovating and developing advanced immunohematology devices. This is another major factor expected to drive growth of the global immunohematology market.
Immunohematology is a branch of “Hematology,” which facilitates the screening of donor blood for antigens, Rh factor, and other blood components such as white blood cells. Commonly known as “Blood Banking,” it prepares blood components for transfusion and helps in reducing transfusion-related diseases such as HIV and thalassemia.
Some Key Findings From the Report:
For the purpose of this report, the global immunohematology market is segmented on the basis of product, application, disease, end-use, and region:
Product Outlook
Application Outlook
Disease Outlook
End-Use Outlook
Region Outlook
Reasons to Buy the Report
Market Size - USD 1,850.5 Million in 2020, Market Growth - CAGR of 4.7%, Market Trends - Rising investment by companies in research and development of innovative and technologically advanced immunohematology devices.
The global immunohematology market size is expected to reach USD 2,678.9 Million in 2028, and register a CAGR of 4.7% during the forecast period. Increasing prevalence of hematological disease, rising demand for platelet and plasma, especially during COVID pandemic, and immune-globin, rapidly increasing number of blood banks by government and private institutions, and increasing incidence of blood-transfusion related diseases are some of the major factors driving market growth. In addition, major players are focusing and investing in improving safety and longevity of blood stored in the blood banks by innovating and developing advanced immunohematology devices. This is another major factor expected to drive growth of the global immunohematology market.
Immunohematology is a branch of “Hematology,” which facilitates the screening of donor blood for antigens, Rh factor, and other blood components such as white blood cells. Commonly known as “Blood Banking,” it prepares blood components for transfusion and helps in reducing transfusion-related diseases such as HIV and thalassemia.
Some Key Findings From the Report:
- Among the product segments, the immunohematology reagents segment accounted for major revenue share of 52.7% in 2020.
- Among the end-use segments, the hospitals segment accounted for the largest revenue share in 2020, due to high patient footfall in hospitals compared to other healthcare end users. The blood bank segment is expected to register the highest revenue growth rate during the forecast period.
- Asia Pacific market was valued at USD 425.6 Million in 2020, and is expected to register a robust revenue growth rate during the forecast period.
- Key players profiled in the report include Siemens Healthcare GmbH, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols, Immucor, Abbott Laboratories, Beckman Coulter, ThermoFisher, and Becton Dickinson and Merck KGaA.
- The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global immunohematology market is segmented on the basis of product, application, disease, end-use, and region:
Product Outlook
- Immunohematology Reagents
- Immunohematology Analyzers
- Automated Analyzers
- Semi-automated analyzers / Non-automated analyzers
Application Outlook
- Pretransfusion testing
- ABO and Rh Typing
- Antibody Detection
- Cross matching
- Investigation of immune hemolysis
- Perinatal testing
- Blood group phenotyping / genotyping
- Leucocyte and platelet serology
Disease Outlook
- Blood-related diseases
- HIV
- Hepatitis
End-Use Outlook
- Hospitals
- Blood banks
- Diagnostic laboratories
Region Outlook
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Immunohematology Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Immunohematology Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Immunohematology Segmentation & Impact Analysis
Chapter 5. Immunohematology Market By Product Type Insights & Trends
Chapter 6. Immunohematology Market By Application Insights & Trends
Chapter 7. Immunohematology Market By Disease Insights & Trends
Chapter 8. Immunohematology Market By End Use Insights & Trends
Chapter 9. Immunohematology Market Regional Outlook
Chapter 10. Competitive Landscape
Chapter 11. Company Profiles
